Company intelligence / Profile preview

Associates

East Falmouth, Massachusetts, United States

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Associates of Cape Cod (ACC) is a global leader in the specialized field of endotoxin and glucan detection. The company was the first to receive an FDA license for the manufacture of Limulus Amebocyte Lysate (LAL) for use as a quality control test for drugs and medical devices. ACC provides a comprehensive range of reagents, instrumentation, and software for endotoxin testing, as well as diagnostic kits for identifying invasive fungal infections. Their products are essential for ensuring the safety of injectable pharmaceuticals and implantable medical devices by detecting pyrogenic contaminants.

Therapeutic areas: Infectious Diseases
Modalities: BiologicRecombinant proteinEnzyme
Industry: Protein Biomarker Diagnostics

Partnerships

Seikagaku Corporation

Beyond the preview

Go deeper on Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Associates.

Explore the full profile